Literature DB >> 1678842

Helix pomatia in breast cancer.

C W Taylor, R Anbazhagan, H Jayatilake, A Adams, B A Gusterson, K Price, R D Gelber, A Goldhirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1678842     DOI： 10.1016/0140-6736(91)91154-m

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.

Authors:  S A Brooks; A J Leathem; R S Camplejohn; W Gregory
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  Characterization of lectins and their specificity in carcinomas-An appraisal.

Authors:  Asma Farhat Sherwani; Sameena Mohmood; Fauzia Khan; Rizwan Hasan Khan; Md Asim Azfer
Journal:  Indian J Clin Biochem       Date:  2003-07

3.  Helix pomatia and prognosis of breast cancer.

Authors:  R A Walker
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

4.  Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.

Authors:  I Kjønniksen; P D Rye; O Fodstad
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

5.  Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.

Authors: 
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.